Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | ESRRB | O95718 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2400089 | 1.00 | CA1 (0.38) | CA1CA2FOLH1ZDHHC7ALDH1A1 | |
| SCHEMBL685012 | 0.87 | ALDH1A1 (0.39) | CA1CA2ZDHHC7ALDH1A1SMN1; SMN2 | |
| SCHEMBL18124773 | 0.87 | ALDH1A1 (0.39) | CA1CA2ZDHHC7ALDH1A1SMN1; SMN2 | |
| SCHEMBL17305959 | 0.87 | ALDH1A1 (0.39) | CA1CA2ZDHHC7ALDH1A1SMN1; SMN2 | |
| SCHEMBL13640440 | 0.84 | CA1 (0.45) | CA1CA2FOLH1ZDHHC7SMN1; SMN2 | |
| SCHEMBL710385 | 0.83 | TSHR (0.48) | CA1CA2FOLH1ALDH1A1TSHR | |
| SCHEMBL579411 | 0.83 | TSHR (0.56) | CA1CA2FOLH1ZDHHC7ALDH1A1 | |
| SCHEMBL18828365 | 0.82 | PTPN1 (0.41) | CA1CA2FOLH1ZDHHC7SMN1; SMN2 | |
| SCHEMBL7105090 | 0.79 | SMN1; SMN2 (0.46) | CA1CA2ZDHHC7ALDH1A1SMN1; SMN2 | |
| SCHEMBL11298047 | 0.78 | CA1 (0.61) | CA1CA2ZDHHC7TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8026081-B2 | Method of producing optically active (S)-7-hydroxy-6-methylheptan-2-one and precursor thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-27 | — | — | US | disclosed |
| US-20090118534-A1 | METHOD OF PRODUCING OPTICALLY ACTIVE (S)-7-HYDROXY-6-METHYLHEPTAN-2-ONE AND PRECURSOR THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-05-07 | — | — | US | disclosed |
| EP-2003211-A9 | PROCESS FOR PRODUCING OPTICALLY ACTIVE (S)-7-HYDROXY-6-METHYLHEPTANE-2-ONE AND PRECURSOR THEREOF | Sumitomo Chemical Company, Limited (JP) | 2009-05-06 | — | — | EP | disclosed |
| EP-2003211-A2 | PROCESS FOR PRODUCING OPTICALLY ACTIVE (S)-7-HYDROXY-6-METHYLHEPTANE-2-ONE AND PRECURSOR THEREOF | Sumitomo Chemical Company, Limited (JP) | 2008-12-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118534-A1 | METHOD OF PRODUCING OPTICALLY ACTIVE (S)-7-HYDROXY-6-METHYLHEPTAN-2-ONE AND PRECURSOR THEREOF | APEH, BCHE, CYP51A1 | CA1 2334/4885CA2 3067/4885FOLH1 514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.